COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,575 Articles (22,415 medRxiv, 8,160 bioRxiv)

Most recent first Previous |  Page 1241: Articles 12401-12410  | Next

Using a physical model and aggregate data from Israel to estimate the current (July 2021 ) efficacy of the Pfizer-BioNTech vaccine
De-Leon, H., Pederiva, F.
10.1101/2021.08.10.21261856 — Posted: 2021-08-11
SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United States
Ngo, T. B., Karkanitsa, M., Adusei, K. M., Graham, L. A., Ricotta, E. E., Darrah, J. R., Blomberg, R. D., Spathies, J., Pauly, K. J., Klumpp-Thomas, C., Travers, J., Mehalko, J., Drew, M., Hall, M. D., Memoli, M. J., Esposito, D., Kozar, R. A., Griggs, C., Cunningham, K. W., Schulman, C. I., Crandall, M., Neavyn, M., Dorfman, J. D., Lai, J. T., Whitehill, J. M., Babu, K. M., Mohr, N. M., Van Heukelom, J., Fell, J. C., Rooke, W., Kalish, H., Thomas, F. D., Sadtler, K.
10.1101/2021.08.10.21261849 — Posted: 2021-08-11
COVID-19 vaccine acceptance among healthcare workers in India: Results from a cross-sectional survey
Mehta, K., Dhaliwal, B., Zodpey, S., Loisate, S., Banerjee, P., GUPTA, M., Shet, A.
10.1101/2021.08.10.21261868 — Posted: 2021-08-11
A Comparative Study on the knowledge and attitude of COVID-19 among Urban and Rural populations of Bangladesh.
Ripon, M. K. H., Khan, N. M., Khan, A. E. M. A., Ahmed, R., Afrin, S., Sayed, M. A., Moghal, D. M. M. R.
10.1101/2021.08.10.21261843 — Posted: 2021-08-11
Impact of the COVID-19 Pandemic on Early Child Cognitive Development: Initial Findings in a Longitudinal Observational Study of Child Health
Deoni, S., Beauchemin, J., Volpe, A., D'Sa, V.
10.1101/2021.08.10.21261846 — Posted: 2021-08-11 Discussion: Onsite | Offsite
Quantifying contact patterns: development and characteristics of the British Columbia COVID-19 population mixing patterns survey (BC-Mix)
Adu, P. A., Binka, M., Bushra, M., Jeong, D., Buller-Taylor, T., Damascene, M. J., Iyaniwura, S., Ringa, N., Velasquez, H., Wong, S., Yu, A., Bartlett, S., Wilton, J., Irvine, M., Otterstatter, M., Janjua, N. Z.
10.1101/2021.08.10.21261872 — Posted: 2021-08-11
Second round statewide survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India
Padma, M. R., Dinesh, P., Sundaresan, R., Athreya, S., Shiju, S., Maroor, P. S., Hande, R. L., Akhtar, J., Chandra, T., Ravi, D., Lobo, E., Ana, Y., Shriyan, P., Desai, A., Rangaiah, A., Munivenkatappa, A., S, K., Gowdara Basawarajappa, S., Sreedhara, H. G., KC, S., Kumari B, A., Umar, N., BA, M., KM, M., Sudarshan, M. K., Vasanthapuram, R., Babu, G. R.
10.1101/2021.08.10.21261842 — Posted: 2021-08-11
COVID-19 Projections for K12 Schools in Fall 2021: Significant Transmission without Interventions
Zhang, Y., Johnson, K., Hassmiller Lich, K., Ivy, J., Keskinocak, P., Mayorga, M., Swann, J. L.
10.1101/2021.08.10.21261726 — Posted: 2021-08-11 Discussion: Onsite
Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: an observational longitudinal study over 12 months
Steinbeis, F., Thibeault, C., Doellinger, F., Ring, R. M., Mittermaier, M., Ruwwe-Gloesenkamp, C., Alius, F., Knape, P., Meyer, H.-J., Lippert, L. J., Helbig, E. T., Grund, D., Temmesfeld-Wollbrueck, B., Suttorp, N., Sander, L. E., Kurth, F., Penzkofer, T., Witzenrath, M., Zoller, T.
10.1101/2021.08.11.21261883 — Posted: 2021-08-11
An ultrapotent neutralizing bispecific antibody with broad spectrum against SARS-CoV-2 variants
Zhang, H., Huang, H., Li, R., Zhang, L., Wang, Z., Li, J., Chen, J., Su, H., Zheng, D., Su, Z., Wang, L., Deng, C., Pei, s., Zhu, S., Li, C., Yuan, Y., Yue, H., Wang, Y., Li, X., Liu, C., Yu, J., Zhang, H., Li, S., Huang, X.
10.1101/2021.08.10.455627 — Posted: 2021-08-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).